Φορτώνει......
A Phase I/II adaptive design for heterogeneous groups with application to a stereotactic body radiation therapy trial
Dose-finding studies that aim to evaluate the safety of single agents are becoming less common, and advances in clinical research have complicated the paradigm of dose finding in oncology. A class of more complex problems, such as targeted agents, combination therapies and stratification of patients...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Pharm Stat |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608237/ https://ncbi.nlm.nih.gov/pubmed/25962576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1686 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|